Roche trims four early assets as Q1 sales slip 6 percent on currency, COVID headwinds
Despite being hit with a continuing decline in COVID-19 sales and a strong Swiss franc, Roche on Wednesday reported first-quarter sales were up 2% at constant exchange rates.